Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

(2016) Giacomo Bellani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Are the High Serum Interleukin-6 and Vascular Endothelial Growth Factor Levels Useful Prognostic Markers in Aggressive Non-Hodgkin Lymphoma Patients?

(2015) Hava Üsküdar Teke et al.   Turkish Journal of Hematology

Acute Respiratory Failure

(2013) James Schneider et al.   CRITICAL CARE CLINICS

An attempt to validate the modification of the American-European consensus definition of acute lung injury/acute respiratory distress syndrome by the Berlin definition in a university hospital

(2013) R. Hernu et al.   INTENSIVE CARE MEDICINE

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

(2013) Balázs Győrffy et al.   PLoS One

Pharmacological Therapies for Pediatric and Neonatal ALI/ARDS: An Evidence-Based Review

(2012) Daniele De Luca et al.   CURRENT DRUG TARGETS

Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation

(2012) Hong Chen et al.   Journal of Proteomics

Defining Severe Pneumonia

(2011) Samuel M. Brown et al.   CLINICS IN CHEST MEDICINE

Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study

(2011) Hong Chen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

JAK1 Activates STAT3 Activity in Non-Small-Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 Signaling

(2011) L. Song et al.   MOLECULAR CANCER THERAPEUTICS

Unknown

(2011) Jochen Grommes et al.   MOLECULAR MEDICINE

Waiting for the Revolution

(2011) E. Marshall   SCIENCE

Cancer-related inflammation: Common themes and therapeutic opportunities

(2011) Frances R. Balkwill et al.   SEMINARS IN CANCER BIOLOGY

Interleukin 6, but Not T Helper 2 Cytokines, Promotes Lung Carcinogenesis

(2010) C. E. Ochoa et al.   Cancer Prevention Research

An Integrative Systems Biology Approach to Understanding Pulmonary Diseases

(2010) Charles Auffray et al.   CHEST

Proteomics-Based Biomarkers in Chronic Obstructive Pulmonary Disease

(2010) Hong Chen et al.   JOURNAL OF PROTEOME RESEARCH

Developments for a growing Japanese patient population: Facilitating new technologies for future health care

(2010) Harubumi Kato et al.   Journal of Proteomics

Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia*

(2009) Samuel M. Brown et al.   CRITICAL CARE MEDICINE

Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells

(2009) N J Sullivan et al.   ONCOGENE

GenCLiP: a software program for clustering gene lists by literature profiling and constructing gene co-occurrence networks related to custom keywords

(2008) Zhong-Xi Huang et al.   BMC BIOINFORMATICS

Inflammation in the development of lung cancer: epidemiological evidence

(2008) Eric A Engels   Expert Review of Anticancer Therapy